PATENT CLAIM ANALYSIS

Application Number: 15752487
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["564", "017000"]

Abstract:
This present disclosure is directed to compound of Formula I and methods of using these compounds in the treatment of conditions in which modulation of a cathepsin, particularly cathepsin L, cathepsin K, and/or cathepsin B, will be therapeutically useful. Formula I: or a solvate or pharmaceutically acceptable salt thereof. Each of R1-R10 are independently selected from the group consisting of: hydrogen, alkoxy, halo, hydroxy, phosphate, phosphate salts, disodium phosphate, diphosphate dimer, diphosphate dimer salt, and sodium diphosphate dimer with at least one of R1-R10 is a phosphate or diphosphate dimer group.

Claim (Index 2):
The compound of  claim 1 , wherein at least one of R1-R5 is a phosphate group.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.73016
- Patent Class: 564.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14876072', '14913140', '14227679', '14232435', '15001505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6961201232126828
- 35 USC 102 Novelty (BERT): 0.5284843730834214
- Combined Prediction Score: 0.6793565481997567
- Mean Citation Score: 236.14417200000003
- Max Citation Score: 240.37149
- Similarity Product: 166.90372167004108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test